Healthcare Integrated Technologies Files Annual Report
Ticker: SSGC · Form: 10-K · Filed: Oct 29, 2024 · CIK: 1584693
Sentiment: neutral
Topics: annual-report, sec-filing, healthcare
TL;DR
HITC filed its 10-K for FY24. Common stock registered under 12(g).
AI Summary
Healthcare Integrated Technologies, Inc. filed its annual report for the fiscal year ended July 31, 2024. The company is incorporated in Nevada and its principal executive offices are located at 311 S. Weisgarber Road, Knoxville, TN 37919. The company's common stock, $0.001 par value, is registered pursuant to Section 12(g) of the Act, but no securities are registered pursuant to Section 12(b).
Why It Matters
This filing provides a yearly overview of Healthcare Integrated Technologies, Inc.'s financial and operational status, crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard annual report and does not contain immediate red flags or significant new disclosures that would indicate a high risk.
Key Numbers
- 001-36564 — Commission File Number (Identifies the specific SEC filing)
- 85-1173741 — I.R.S. Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Healthcare Integrated Technologies, Inc. (company) — Registrant
- July 31, 2024 (date) — Fiscal year end
- Nevada (jurisdiction) — State of Incorporation
- 311 S. Weisgarber Road, Knoxville, TN 37919 (address) — Principal Executive Offices
- Common Stock, $0.001 par value (security) — Registered Security
FAQ
What is the primary purpose of this Form 10-K filing?
This Form 10-K is an annual report required to be filed by Healthcare Integrated Technologies, Inc. pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, for the fiscal year ended July 31, 2024.
Which class of securities is registered with the SEC for Healthcare Integrated Technologies, Inc.?
The Common Stock, $0.001 par value, is registered pursuant to Section 12(g) of the Act.
Are any of Healthcare Integrated Technologies, Inc.'s securities registered under Section 12(b) of the Act?
No, the filing explicitly states 'Securities registered pursuant to Section 12(b) of the Act: None'.
Where are Healthcare Integrated Technologies, Inc.'s principal executive offices located?
The principal executive offices are located at 311 S. Weisgarber Road, Knoxville, TN 37919.
Has Healthcare Integrated Technologies, Inc. submitted and posted Interactive Data Files required by Rule 405 of Regulation S-T?
The filing indicates 'Yes' for the question regarding submission and posting of Interactive Data Files required by Rule 405 of Regulation S-T during the preceding 12 months.
Filing Stats: 4,514 words · 18 min read · ~15 pages · Grade level 14.2 · Accepted 2024-10-29 09:25:32
Key Financial Figures
- $0.001 — ction 12(g) of the Act: Common Stock, $0.001 par value (Title of class) Indicate
- $10,651 — o on January 13, 2015. The exchange for $10,651 was represented by 250,000 shares of th
Filing Documents
- form10-k.htm (10-K) — 991KB
- ex10-5.htm (EX-10.5) — 7KB
- ex10-7.htm (EX-10.7) — 5KB
- ex10-8.htm (EX-10.8) — 5KB
- ex31-1.htm (EX-31.1) — 37KB
- ex32-1.htm (EX-32.1) — 14KB
- form10-k_001.jpg (GRAPHIC) — 4KB
- ex10-5_001.jpg (GRAPHIC) — 1302KB
- ex10-5_002.jpg (GRAPHIC) — 1428KB
- ex10-5_003.jpg (GRAPHIC) — 1432KB
- ex10-5_004.jpg (GRAPHIC) — 1594KB
- ex10-5_005.jpg (GRAPHIC) — 1607KB
- ex10-5_006.jpg (GRAPHIC) — 1300KB
- ex10-5_007.jpg (GRAPHIC) — 297KB
- ex10-5_008.jpg (GRAPHIC) — 357KB
- ex10-7_001.jpg (GRAPHIC) — 1356KB
- ex10-7_002.jpg (GRAPHIC) — 1140KB
- ex10-7_003.jpg (GRAPHIC) — 1141KB
- ex10-7_004.jpg (GRAPHIC) — 1109KB
- ex10-7_005.jpg (GRAPHIC) — 282KB
- ex10-7_006.jpg (GRAPHIC) — 871KB
- ex10-8_001.jpg (GRAPHIC) — 626KB
- ex10-8_002.jpg (GRAPHIC) — 1428KB
- ex10-8_003.jpg (GRAPHIC) — 1641KB
- ex10-8_004.jpg (GRAPHIC) — 594KB
- ex10-8_005.jpg (GRAPHIC) — 350KB
- ex10-8_006.jpg (GRAPHIC) — 534KB
- 0001493152-24-042789.txt ( ) — 32937KB
- hitc-20240731.xsd (EX-101.SCH) — 35KB
- hitc-20240731_cal.xml (EX-101.CAL) — 49KB
- hitc-20240731_def.xml (EX-101.DEF) — 159KB
- hitc-20240731_lab.xml (EX-101.LAB) — 339KB
- hitc-20240731_pre.xml (EX-101.PRE) — 283KB
- form10-k_htm.xml (XML) — 561KB
BUSINESS
ITEM 1. BUSINESS. 4
RISK FACTORS
ITEM 1A. RISK FACTORS . 5
UNRESOLVED STAFF COMMENTS
ITEM 1B. UNRESOLVED STAFF COMMENTS. 10
PROPERTIES
ITEM 2. PROPERTIES . 10
LEGAL PROCEEDINGS
ITEM 3. LEGAL PROCEEDINGS. 10
MINE SAFETY DISCLOSURES
ITEM 4. MINE SAFETY DISCLOSURES . 10 PART II 11
MARKET FOR OUR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
ITEM 5. MARKET FOR OUR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES . 11
SELECTED FINANCIAL DATA
ITEM 6. SELECTED FINANCIAL DATA . 12
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. 12
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. 20
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA . 20
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE . 20
CONTROLS AND PROCEDURES
ITEM 9A. CONTROLS AND PROCEDURES . 20
OTHER INFORMATION
ITEM 9B. OTHER INFORMATION 21 PART III 22
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE . 22
EXECUTIVE COMPENSATION
ITEM 11. EXECUTIVE COMPENSATION . 25
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS . 29
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE . 31
PRINCIPAL ACCOUNTING FEES AND SERVICES
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES . 32 PART IV 33
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 33
SIGNATURES
SIGNATURES 34 2 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K (this "Report") contains "forward-looking statements" within the meaning of the Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements discuss matters that are not historical facts. Because they discuss future events or conditions, forward-looking statements may include words such as "anticipate," "believe," "estimate," "intend," "could," "should," "would," "may," "seek," "plan," "might," "will," "expect," "predict," "project," "forecast," "potential," "continue", negatives thereof or similar expressions. These forward-looking statements are found at various places throughout this Annual Report and include information concerning: possible or assumed future results of our operations; business strategies; future cash flows; financing plans; plans and objectives of management; any other statements regarding future operations, future cash needs, business plans and future financial results; and any other statements that are not historical facts. From time to time, forward-looking statements are also included in our other periodic reports on Forms 10-Q and 8-K, in our press releases, in our presentations, on our website and in other materials released to the public. Any or all the forward-looking statements included in this Annual Report and in any other reports or public statements made by us are not guarantees of future performance and may turn out to be inaccurate. These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to risks, uncertainties and other factors. Many of those factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. Conside